Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-05-14
1982-04-06
Miller, Edward A.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
260112B, 128659, 424 15, 424 9, 422 61, A61K 4900, A61K 4300, G01T 100, B65D 7100
Patent
active
043235468
ABSTRACT:
Anti human chorionic gonadotropin (anti-hCG) and/or anti human chorionic gonadotropin- beta subunit (anti-hCG-.beta.) labeled with Technetium-99M are/is administered to a human. The biodistribution of the labeled composition is monitored in order to determine whether the labeled composition accumulates at cancer sites, e.g. tumors that produce human chorionic gonadotropin (hCG), human chorionic gonadotropin-like material, and a compound similar to and/or identical to the beta-chain of chorionic gonadotropin, or mixtures thereof which would bind specifically to anti-hCG and/or anti-hCG-.beta..
REFERENCES:
patent: 3927193 (1975-12-01), Hansen et al.
patent: 4150149 (1979-04-01), Wolfsen et al.
McManus et al., Can. Res., 36, pp. 2367-3481, Sep. 1976.
Crockford David R.
Rhodes Buck A.
Cook Paul J.
Miller Edward A.
Nuc Med Inc.
Nucker Christine M.
University Patents Inc
LandOfFree
Method and composition for cancer detection in humans does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for cancer detection in humans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for cancer detection in humans will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-592237